C4 Therapeutics, Inc.

C4 Therapeutics, Inc. financial statements

C4 Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 35.95M10-K
Net income−USD 104.99M10-K
Cash and equivalentsUSD 74.6M10-Q
Total debtUSD 59.98MEODHD

C4 Therapeutics, Inc. financials on 6ix · C4 Therapeutics, Inc. on 6ix